Varex Imaging Corporation (VREX)
7.81
0.07 (0.90%)
At close: Apr 11, 2025, 3:59 PM
7.83
0.20%
After-hours: Apr 11, 2025, 04:27 PM EDT
Varex Imaging Revenue Breakdown
| Period Ending | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|
| Industrial Segment Revenue | 61.3M | 60.5M | 57.4M | 50.1M |
| Industrial Segment Revenue Growth | +1.32% | +5.40% | +14.57% | n/a |
| Medical Segment Revenue | 144.4M | 148.6M | 148.8M | 139.9M |
| Medical Segment Revenue Growth | -2.83% | -0.13% | +6.36% | n/a |
Revenue by Geography
| Period Ending | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Oct 1, 2021 | Oct 2, 2020 | Sep 27, 2019 | Sep 28, 2018 | Sep 29, 2017 |
|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 266.5M | 281.8M | 273.3M | 268.5M | 251.8M | 229M | 243.1M | 239.8M |
| Americas Revenue Growth | -5.43% | +3.11% | +1.79% | +6.63% | +9.96% | -5.80% | +1.38% | n/a |
| Asia Pacific Revenue | 264.2M | 320.9M | 305.3M | 273.3M | 231.5M | 269M | 254.5M | 238.8M |
| Asia Pacific Revenue Growth | -17.67% | +5.11% | +11.71% | +18.06% | -13.94% | +5.70% | +6.57% | n/a |
| Emea Revenue | 280.3M | 290.7M | 280.8M | 276.3M | 249.8M | 275.3M | 268.8M | 219.5M |
| Emea Revenue Growth | -3.58% | +3.53% | +1.63% | +10.61% | -9.26% | +2.42% | +22.46% | n/a |
| United States Revenue | 257.7M | 275.1M | 263.7M | 262.3M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -6.32% | +4.32% | +0.53% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 33.8M | 34.3M | 35.6M | 35.5M | 32.4M | 31.9M | 32.1M | 34.1M | 30.3M | 29.7M | 30.2M | 25.3M | 33.1M | 31.3M | 29.2M | 30.6M | 34.4M | 40.7M | 31.4M | 35.3M | 34.8M | 35.8M | 35.2M | 31.1M | 30.8M | 32.2M | 35.2M | 30.9M | 28.2M | 29.2M | 26.3M | 19.7M | 26.9M | 22.3M | 20.6M | 20.8M | 22M | 18.6M |
| Selling, General, and Administrative Revenue Growth | -1.46% | -3.65% | +0.28% | +9.57% | +1.57% | -0.62% | -5.87% | +12.54% | +2.02% | -1.66% | +19.37% | -23.56% | +5.75% | +7.19% | -4.58% | -11.05% | -15.48% | +29.62% | -11.05% | +1.44% | -2.79% | +1.70% | +13.18% | +0.97% | -4.35% | -8.52% | +13.92% | +9.57% | -3.42% | +11.03% | +33.50% | -26.77% | +20.63% | +8.25% | -0.96% | -5.45% | +18.28% | n/a |
| Research and Development Revenue | 23.5M | 21.9M | 22M | 22.6M | 20.5M | 21.8M | 20M | 23M | 20M | 20.2M | 20.2M | 18.9M | 17.7M | 17.8M | 19.2M | 18.2M | 16.7M | 17.3M | 19M | 20.9M | 21.7M | 19.6M | 20.9M | 18.8M | 18.8M | 20.7M | 20.5M | 22M | 19.7M | 21.9M | 17.7M | 14.4M | 13.3M | 13.9M | 14M | 13.1M | 12.5M | 15.7M |
| Research and Development Revenue Growth | +7.31% | -0.45% | -2.65% | +10.24% | -5.96% | +9.00% | -13.04% | +15.00% | -0.99% | 0.00% | +6.88% | +6.78% | -0.56% | -7.29% | +5.49% | +8.98% | -3.47% | -8.95% | -9.09% | -3.69% | +10.71% | -6.22% | +11.17% | 0.00% | -9.18% | +0.98% | -6.82% | +11.68% | -10.05% | +23.73% | +22.92% | +8.27% | -4.32% | -0.71% | +6.87% | +4.80% | -20.38% | n/a |